全球癌症基因治疗市场规模和预测：按类型、最终用途和地区分析，2022-2029 年

2021 年全球癌症基因治疗市场价值约为 16.8 亿美元，预计在 2022-2029 年预测期内将以超过 19.99% 的健康增长率增长。

癌症基因疗法是一种新的治疗方法，通过将新基因引入癌细胞和附近组织来帮助杀死或减缓癌症的生长。 由于该疗法的灵活性以及在临床试验中使用多种基因和载体取得了良好的效果，作为一种治疗人类疾病的新方法而备受关注。 蓬勃发展的医药行业、激增的抗癌新药需求以及政府加大扶持力度是推动全球市场需求的关键因素，是一个因素。

全球癌症发病率上升是市场增长的主要驱动力。 据美国国家癌症研究所估计，2018 年癌症患者人数为 1810 万人，预计到 2040 年将达到 2950 万人。 因此，癌症患病率的增加推动了对广泛的诊断和治疗选择的需求，从而推动了癌症基因治疗市场的增长。 此外，在癌症基因治疗方面不断提高的技术进步和不断扩大的研发投资为未来几年的市场增长创造了有利可图的机会。 然而，与基因治疗相关的高成本和不良免疫反应阻碍了整个 2022-2029 年预测期内的市场增长。

全球癌症基因治疗市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于成熟的市场参与者的存在以及对该地区医疗设施投资的增加，北美在收入方面占据了市场主导地位。 另一方面，预计欧洲将在预测期内以最高复合年增长率增长。 政府机构增加对新疗法的研究经费以及对新疗法的需求增加等因素正在推动预测期内的市场增长。

本报告中包含的主要市场参与者是：

• Abeona Therapeutics Inc.
• Asclepius Biopharmaceutical Inc.
• 蓝鸟生物公司
• 葛兰素史克公司
• Introgen Therapeutics Inc.
• 默克公司
• 生物取消墨水
• 提升生物
• Genelux 有限公司
• Oncogenex Pharmaceuticals Inc.

近期发展。

• 2022 年 1 月，Ori Biotech Ltd. 完成了超过 1 亿美元的 B 轮融资，帮助推出其创新细胞和基因治疗製造平台的关键人员宣布，该平台将用于扩大
• 2021 年 6 月，卫材与百时美施贵宝达成合作协议，共同开发 MORAb-202 并将其商业化，MORAb-202 是卫材用于晚期实体瘤的 ADC。

研究范围：全球癌症基因治疗市场

• 历史数据：2019-2020-2021
• 基本估算年份：2021 年
• 预测期间：2022-2029
• 报告范围盈利预测、公司排名、竞争格局、增长因素、趋势等。
• 涵盖的细分市场类型、最终用途、地区
• 区域覆盖范围北美；欧洲；亚太地区；拉丁美洲；世界其他地区
• 定制范围 报告定制是免费的（八小时分析师时间）。 添加/更改国家、地区、细分范围*。

这项研究的目的是定义近年来各个细分市场和国家/地区的市场规模，并预测它们在未来几年的价值。 本报告旨在捕捉被调查国家行业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

按类型

• 溶瘤生物疗法
• 基因转移免疫疗法
• 基因转移

由最终用户

• 研究所
• 生物製药公司
• 诊断中心
• 其他

按地区

• 北美
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 法国
• 西班牙
• 意大利
• 净资产收益率
• 亚太地区
• 中国
• 印度
• 日本
• 澳大利亚
• 韩国
• 下包
• 拉丁美洲
• 巴西
• 墨西哥
• 世界其他地区

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 癌症基因治疗市场：按地区划分，2019-2029 年
  • 癌症基因治疗市场：按类型分类，2019-2029
  • 癌症基因治疗市场，按最终用途分类，2019-2029 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章癌症基因治疗的全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第3章全球癌症基因治疗市场动态

• 癌症基因治疗市场影响分析（2019-2029）
  • 市场驱动力
    • 抗癌新药需求激增
    • 全球癌症发病率上升
  • 市场挑战
    • 基因治疗很昂贵
    • 不需要的免疫反应
  • 市场机会
    • 癌症基因治疗技术进步的增加
    • 增加研发投资

第 4 章全球癌症基因治疗市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的结论和建议
• 顶级投资机会
• 关键成功策略

第 5 章风险评估 COVID-19 影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球癌症基因治疗市场，按类型

• 市场概况
• 全球癌症基因治疗市场：按类型划分的表现 - 潜力分析
• 2019-2029 年全球癌症基因治疗市场、按类型估计和预测
• 癌症基因治疗市场，细分分析
  • 溶瘤生物疗法
  • 基因引导的免疫疗法
  • 基因转移

第 7 章：全球癌症基因治疗市场，按最终用户分类

• 市场概况
• 全球癌症基因治疗市场：按最终用途分类的结果 - 潜力分析
• 2019-2029 年世界癌症基因治疗市场，按最终用途估算和预测
• 癌症基因治疗市场，细分分析
  • 研究机构
  • 生物製药公司
  • 诊断中心
  • 其他

第 8 章全球癌症基因治疗市场：区域分析

• 癌症基因治疗市场：按地区划分的市场概况
• 北美
  • 美国
    • 按类型估算和预测，2019-2029 年
    • 2019-2029 年按最终用途估算和预测
  • 加拿大
• 欧洲癌症基因治疗市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太地区癌症基因治疗市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲癌症基因治疗市场概况
  • 巴西
  • 墨西哥
• 世界其他地区

第 9 章衝突信息

• 顶级市场策略
• 公司简介
  • Abeona Therapeutics Inc.
    • 主要信息
    • 概览
    • 财务信息（取决于数据可用性）
    • 产品概述
    • 近期趋势
  • Asklepios BioPharmaceutical Inc.
  • Bluebird bio Inc.
  • GlaxoSmithKlineInc.
  • Introgen TherapeuticsInc.
  • MerckKGaA
  • BioCancell Inc.
  • Elevate BioInc.
  • Genelux Corporation
  • OncoGenex Pharmaceuticals Inc.

第 10 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Cancer Gene Therapy Market is valued at approximately USD 1.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 19.99% over the forecast period 2022-2029. Cancer gene therapy is a new treatment modality that assists in the introduction of new genes into a cancerous cell or the nearby tissue that leads to cell death or slows the growth of cancer. This treatment technique is flexible and a variety of genes and vectors are being utilized in clinical trials that present positive results, which is gaining huge popularity as a novel method for treating human ailments. The flourishing development of the pharmaceutical industry, surging demand for novel cancer therapeutics, and rising government support are the primary factors that are fostering market demand across the globe.

The rising incidences of cancer globally are a key driving factor for market growth. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the Cancer Gene Therapy Market. Moreover, the increasing technological advancements in cancer gene therapy, as well as growing R&D investments, are creating lucrative opportunities for market growth in the foreseen years. However, the high cost associated with gene therapy and unwanted immune responses is hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cancer Gene Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the presence of well-established market players and increasing investment in healthcare facilities in the region. Whereas, Europe is expected to grow at the highest CAGR during the forecast period. Factors such as rising research funding for novel therapeutics by government bodies, as well as growing demand for novel therapeutics are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

• Abeona Therapeutics Inc.
• Asklepios BioPharmaceutical Inc.
• Bluebird bio Inc.
• GlaxoSmithKlineInc.
• Introgen TherapeuticsInc.
• MerckKGaA
• BioCancell Inc.
• Elevate Bio Inc.
• Genelux Corporation
• OncoGenex Pharmaceuticals Inc.

Recent Developments in the Market:

• In January 2022, Ori Biotech Ltd. publicized that the company has achieved above USD 100 million in funding in a Series B funding round, which is planned to use for the expansion of key personnel to support the launch of its innovative cell and gene therapy manufacturing platform.
• In June 2021, Eisai and Bristol Myers Squibb entered collaborative agreement to form and marketing of MORAb-202, Eisai's ADC for advanced solid tumors.

Report Scope:Global Cancer Gene Therapy Market

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, End Use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent to up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Oncolytic Virotherapy
• Gene Induced Immunotherapy
• Gene Transfer

By End Use:

• Research Institutes
• Biopharmaceutical Companies
• Diagnostic Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Cancer Gene Therapy Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Cancer Gene Therapy Market, by Type, 2019-2029 (USD Billion)
  • 1.2.3. Cancer Gene Therapy Market, by End Use, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cancer Gene Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Gene Therapy Market Dynamics

• 3.1. Cancer Gene Therapy Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Surging demand for novel cancer therapeutics
    • 3.1.1.2. Rising incidences of cancer globally
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost is associated with gene therapy
    • 3.1.2.2. Unwanted immune responses
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing technological advancements in cancer gene therapy
    • 3.1.3.2. Growing R&D investments

Chapter 4. Global Cancer Gene Therapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cancer Gene Therapy Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Cancer Gene Therapy Market by Type, Performance - Potential Analysis
• 6.3. Global Cancer Gene Therapy Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Cancer Gene Therapy Market, Sub Segment Analysis
  • 6.4.1. Oncolytic Virotherapy
  • 6.4.2. Gene Induced Immunotherapy
  • 6.4.3. Gene Transfer

Chapter 7. Global Cancer Gene Therapy Market, by End Use

• 7.1. Market Snapshot
• 7.2. Global Cancer Gene Therapy Market by End Use, Performance - Potential Analysis
• 7.3. Global Cancer Gene Therapy Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
• 7.4. Cancer Gene Therapy Market, Sub Segment Analysis
  • 7.4.1. Research Institutes
  • 7.4.2. Biopharmaceutical Companies
  • 7.4.3. Diagnostic Centers
  • 7.4.4. Others

Chapter 8. Global Cancer Gene Therapy Market, Regional Analysis

• 8.1. Cancer Gene Therapy Market, Regional Market Snapshot
• 8.2. North America Cancer Gene Therapy Market
  • 8.2.1. U.S. Cancer Gene Therapy Market
    • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End Use breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Cancer Gene Therapy Market
• 8.3. Europe Cancer Gene Therapy Market Snapshot
  • 8.3.1. U.K. Cancer Gene Therapy Market
  • 8.3.2. Germany Cancer Gene Therapy Market
  • 8.3.3. France Cancer Gene Therapy Market
  • 8.3.4. Spain Cancer Gene Therapy Market
  • 8.3.5. Italy Cancer Gene Therapy Market
  • 8.3.6. Rest of Europe Cancer Gene Therapy Market
• 8.4. Asia-Pacific Cancer Gene Therapy Market Snapshot
  • 8.4.1. China Cancer Gene Therapy Market
  • 8.4.2. India Cancer Gene Therapy Market
  • 8.4.3. Japan Cancer Gene Therapy Market
  • 8.4.4. Australia Cancer Gene Therapy Market
  • 8.4.5. South Korea Cancer Gene Therapy Market
  • 8.4.6. Rest of Asia Pacific Cancer Gene Therapy Market
• 8.5. Latin America Cancer Gene Therapy Market Snapshot
  • 8.5.1. Brazil Cancer Gene Therapy Market
  • 8.5.2. Mexico Cancer Gene Therapy Market
• 8.6. Rest of The World Cancer Gene Therapy Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Abeona Therapeutics Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Asklepios BioPharmaceutical Inc.
  • 9.2.3. Bluebird bio Inc.
  • 9.2.4. GlaxoSmithKlineInc.
  • 9.2.5. Introgen TherapeuticsInc.
  • 9.2.6. MerckKGaA
  • 9.2.7. BioCancell Inc.
  • 9.2.8. Elevate BioInc.
  • 9.2.9. Genelux Corporation
  • 9.2.10. OncoGenex Pharmaceuticals Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Cancer Gene Therapy Market, report scope
• TABLE 2. Global Cancer Gene Therapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Cancer Gene Therapy Market estimates & forecasts by Type 2019-2029 (USD Billion)
• TABLE 4. Global Cancer Gene Therapy Market estimates & forecasts by End Use 2019-2029 (USD Billion)
• TABLE 5. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Cancer Gene Therapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Cancer Gene Therapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Cancer Gene Therapy Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Cancer Gene Therapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Cancer Gene Therapy Market
• TABLE 70. List of primary sources, used in the study of global Cancer Gene Therapy Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Cancer Gene Therapy Market, research methodology
• FIG 2. Global Cancer Gene Therapy Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Cancer Gene Therapy Market, key trends 2021
• FIG 5. Global Cancer Gene Therapy Market, growth prospects 2022-2029
• FIG 6. Global Cancer Gene Therapy Market, porters 5 force model
• FIG 7. Global Cancer Gene Therapy Market, pest analysis
• FIG 8. Global Cancer Gene Therapy Market, value chain analysis
• FIG 9. Global Cancer Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Cancer Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Cancer Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Cancer Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Cancer Gene Therapy Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Cancer Gene Therapy Market, regional snapshot 2019 & 2029
• FIG 15. North America Cancer Gene Therapy Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Cancer Gene Therapy Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Cancer Gene Therapy Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Cancer Gene Therapy Market 2019 & 2029 (USD Billion)
• FIG 19. Global Cancer Gene Therapy Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable